Crossmark

Disruption of Sema3A/Plexin‐A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination

Crossref DOI link: https://doi.org/10.15252/emmm.201910378

Published Online: 2019-09-30

Published Print: 2019-11-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Binamé, Fabien

Pham‐Van, Lucas D

Spenlé, Caroline

Jolivel, Valérie

Birmpili, Dafni

Meyer, Lionel A

Jacob, Laurent

Meyer, Laurence

Mensah‐Nyagan, Ayikoé G

Po, Chrystelle

Van der Heyden, Michaël

Roussel, Guy

Bagnard, Dominique https://orcid.org/0000-0002-5261-902X
Funding

Funding for this research was provided by:

Agence Nationale de la Recherche (Labex Medalis‐ MEDALIS‐DBA‐2016)

Institut National de la Santé et de la Recherche Médicale
License Information

Version of Record valid from 2019-09-30
More Information

Publication History

Received: 2019-01-26

Accepted: 2019-09-04

Published: 2019-09-30